- Presentations
- 3
- Markets
- 1
Taltz is a brand of Ixekizumab marketed by Eli Lilly, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ixekizumab
- Brand owner
- Eli Lilly
- Registered in
- United States
- Strengths and forms
- 20 mg/0.25 mL injection, 40 mg/0.5 mL injection, 80 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Taltz 20 mg/0.25 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Taltz 40 mg/0.5 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Taltz 80 mg/1 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Taltz
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.